Literature DB >> 20693206

Epidemiologic, socioeconomic and psychosocial aspects in lupus erythematosus.

E Aberer1.   

Abstract

Epidemiologic, socioeconomic, and psychosocial factors play an important role in health care and handling of patients with the various clinical forms of lupus erythematosus (LE). Patients with LE are mostly young women; adolescents and some ethnic groups are especially prone to a severe course of disease. The unpredictable and fluctuating flares of disease, the need for longterm treatment, and the side effects and damage caused by the disease itself severely reduce quality of life. Problems arise, involving family members, adherence to medical advice and therapy, communication and self management. Socioeconomically, patients are often unable to take regular employment and to pay for health insurance. Stress factors that arise have a negative impact on the course of disease, increasing both fatigue and the basic burden of illness. Healthcare professionals must pay careful attention to all these items, as they attempt to treat flares, minimize drug side effects, provide pain relief, arrange communication and exercise programs along with behavioral and psychosocial interventions in multidisciplinary cooperation, and also involve and support family members.

Entities:  

Mesh:

Year:  2010        PMID: 20693206     DOI: 10.1177/0961203310370348

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  11 in total

1.  Stress and skin leukocyte trafficking as a dual-stage process.

Authors:  Elad Neeman; Lee Shaashua; Marganit Benish; Gayle G Page; Oded Zmora; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2011-09-19       Impact factor: 7.217

2.  Perceived stress and reported cognitive symptoms among Georgia patients with systemic lupus erythematosus.

Authors:  L Plantinga; S S Lim; C B Bowling; C Drenkard
Journal:  Lupus       Date:  2017-02-23       Impact factor: 2.911

3.  A multicentre, cross-sectional study on quality of life in patients with cutaneous lupus erythematosus.

Authors:  R Vasquez; D Wang; Q P Tran; B Adams-Huet; M-M Chren; M I Costner; J B Cohen; V P Werth; B F Chong
Journal:  Br J Dermatol       Date:  2012-09-13       Impact factor: 9.302

4.  Vicarious Racism Stress and Disease Activity: the Black Women's Experiences Living with Lupus (BeWELL) Study.

Authors:  Connor D Martz; Amani M Allen; Thomas E Fuller-Rowell; Erica C Spears; S Sam Lim; Cristina Drenkard; Kara Chung; Evelyn A Hunter; David H Chae
Journal:  J Racial Ethn Health Disparities       Date:  2019-06-18

5.  Racial Discrimination, Disease Activity, and Organ Damage: The Black Women's Experiences Living With Lupus (BeWELL) Study.

Authors:  David H Chae; Connor D Martz; Thomas E Fuller-Rowell; Erica C Spears; Tianqi Tenchi Gao Smith; Evelyn A Hunter; Cristina Drenkard; S Sam Lim
Journal:  Am J Epidemiol       Date:  2019-08-01       Impact factor: 4.897

Review 6.  Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance.

Authors:  Laura Holloway; Louise Humphrey; Louise Heron; Claire Pilling; Helen Kitchen; Lise Højbjerre; Martin Strandberg-Larsen; Brian Bekker Hansen
Journal:  Health Qual Life Outcomes       Date:  2014-07-22       Impact factor: 3.186

7.  Prevalence of hyposalivation in patients with systemic lupus erythematosus in a brazilian subpopulation.

Authors:  Cristhiane Almeida Leite; Marcial Francis Galera; Mariano Martínez Espinosa; Paulo Ricardo Teles de Lima; Vander Fernandes; Álvaro Henrique Borges; Eliane Pedra Dias
Journal:  Int J Rheumatol       Date:  2015-01-11

8.  Self-care model application to improve self-care agency, self-care activities, and quality of life in patients with systemic lupus erythematosus.

Authors:  Kusnanto Kusnanto; Ni Putu Wulan Purnama Sari; Harmayetty Harmayetty; Ferry Efendi; Joko Gunawan
Journal:  J Taibah Univ Med Sci       Date:  2018-08-18

Review 9.  Data quality challenges in systemic lupus erythematosus trials: how can this be optimized?

Authors:  Marilyn C Pike; Lexy Kelley
Journal:  Curr Rheumatol Rep       Date:  2012-08       Impact factor: 4.592

10.  Resilience and treatment adhesion in patients with systemic lupus erythematosus.

Authors:  Daniella Antunes Pousa Faria; Luciana Silva Revoredo; Maria José Vilar; Maia Eulália Maria Chaves
Journal:  Open Rheumatol J       Date:  2014-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.